Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein.
about
Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster.Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B geneKinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster.Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism.Chance and serendipity in science: two examples from my own career.Bile acids regulate hepatic low density lipoprotein receptor activity in the hamster by altering cholesterol flux across the liver.Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.Accumulation of 99mTc-low-density lipoprotein in human malignant gliomaAutoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitusEpitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end productsHow bile acids differ: studies of receptor-mediated LDL uptake.A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.Alterations in serum lipid profile patterns in oral cancerLipid profile in oral submucous fibrosis.The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster.Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.Pathophysiology of human lipoprotein receptors: clinical consequences of a cellular defect.The biochemistry of diabetes.Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor.Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL.Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.Purification of low density lipoprotein receptor from liver and its quantification by anti-receptor monoclonal antibodiesIdentification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry.The effects of chemically modifying serum apolipoproteins on their ability to activate lipoprotein lipase.Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.Significance of alterations in plasma lipid profile levels in breast cancer.Bottom up design of nanoparticles for anti-cancer diapeutics: "put the drug in the cancer's food".The anti-leukemic and lipid lowering effects of imatinib are not hindered by statins in CML: a retrospective clinical study and in vitro assessment of lipid-genes transcription.Apolipoproteins and Gallstone Disease
P2860
Q33822165-2B831A1F-6AB5-400E-BB9B-BEE239904026Q34144772-0A162F30-86B9-4602-BA14-51927A2D0F86Q34203843-2B749C74-5FEF-4FA2-B442-2F7B9EEAD055Q34218935-431CB763-A8A6-40C9-A041-20D79F93F5F2Q34554723-3083B76C-569E-4E8F-A3CA-194A5D37AEE6Q34561616-653B813F-133C-4DE1-930C-3AEEE2D72C05Q34577599-769B9455-04AF-4EAF-BF1B-4DE40A391286Q35205770-6CAC6C91-918B-45EC-A9F8-28C5C1484DB1Q35516016-8AFEACD8-1300-46D7-AE99-E3FBA9E1474DQ35596077-5AFF1CE4-B872-4977-9ED2-A1A808E98CD2Q35788419-32799718-644C-4168-94F1-CE82A0ED0F11Q36080350-E31C56EC-CA94-449C-BBB5-A64012DFDAFBQ36261698-759A531C-6EA3-48D3-8F6D-11A031471055Q36502603-8A8A754C-34B5-45BE-A778-B6455662C51CQ36646915-41D55E4C-540A-4C6D-9DF7-3DF6DFE55D55Q36991935-87F741E1-7FCE-44C7-A7CB-34219718D917Q37199105-22265F97-F9FE-45A6-83D1-9F64003AF3ACQ37291773-3E48178A-7615-4847-9C79-749B549C2A0CQ37372758-8E9B6FBA-CC11-47DA-AE95-9BFB0196EE7DQ37546278-29EA647D-EFA4-4860-9AC4-F8483EA6B793Q37616687-2546E8F5-F0BF-425F-A389-12F02FB5A90CQ38332334-F67E0941-164A-41FC-AF4A-62E34CF4C661Q39522583-D8B9DD98-9512-479F-9AB3-B21019BAB023Q39650599-A87ABF51-8577-4DBE-BAA7-DC8883C9F79BQ40510778-5386B5E4-0394-40E6-80FA-75D5F9FF1E04Q40639637-9E753030-CE58-490A-8C83-E9136854E2DBQ41541678-02FC070A-926B-454D-8FDA-1B3AC86E0AD8Q41661872-80024EA8-DC5A-49D7-AAAC-1F9086D636F0Q41832803-A0904C33-261C-417C-B921-3D2ECB0B828AQ42836742-E764903B-FEE6-4A6B-ACB4-59AAD99412B4Q42855544-517A151C-41C5-450E-9331-9A55E2DF8008Q46239308-6F2DA287-E38C-41FA-B1A6-C77722F2C190Q46739775-A8E1BDAD-DCD6-4FD9-AE30-0BCD8A098A32Q51159201-4FA9986D-0437-4A88-BCF3-3A266481CC6AQ51801542-8CE3D792-89C2-473A-B1B6-00D6D115CF45Q58260018-04CF4A35-3520-42D0-9B9D-91D9DE3DAF16
P2860
Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein.
description
1983 nî lūn-bûn
@nan
1983 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@ast
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@en
type
label
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@ast
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@en
prefLabel
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@ast
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@en
P2093
P2860
P356
P1476
Receptor-mediated catabolism o ...... lated low density lipoprotein.
@en
P2093
J L Witztum
U P Steinbrecher
Y A Kesaniemi
P2860
P304
P356
10.1172/JCI110849
P407
P577
1983-04-01T00:00:00Z